[Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Up to now 65 patients with erectile dysfunction were treated by means of corpus cavernosum-autoinjection-therapy (CAT). The only side effect observed were 6 prolonged erections, which could successfully be treated in 3 cases by puncture and aspiration of the corpora cavernosa. In another 3 cases prolonged erection subsided after an intracavernous injection of 2 mg metaraminol. Erection induced by CAT was immediately interrupted by metaraminol in 10 other patients.
D000328:Adult; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use*; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects*; D010410:Penile Erection / Q000187:drug effects*; D010413:Penis / Q000187:drug effects; D010646:Phentolamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011317:Priapism / Q000139:chemically induced* / Q000188:drug therapy
D008680:Metaraminol; D010208:Papaverine; D010646:Phentolamine
Metaraminol--ein Antidot bei SKAT-bedingter prolongierter Erektion.